Leadership Team
Marco Marchetti
CEO
Marco Marchetti is a biotechnologist and a businessman who has founded and successfully managed several companies in the Biotech and Pharmaceutical sectors among which FB Vision, serving as Executive Senior VP and co-founder, Longeva Health, as co-founder and former CEO, FB Animal Health as co-founder and CEO, FB Health (today part of Neuraxpharm group), as co-founder and former Managing Director. He also serves as Board Member in several pharma-biotech companies.
Jérémie Coignus
International Strategic Marketing Director
Jérémie Coignus is French/Spanish citizen, based in Barcelona, holding an Italian/French master’s degree of International Management. Passionate about Dermatology and Aesthetic Medicine, he has been working in the field for about 15 years, always in between business development, sales and marketing. He joined the organisation in 2015, first introducing Fluorescent Light Energy in the Spanish market.
Mez Kerkeria
Regional Director of South Asia Pacific
Mez Kerkeria joined the organisation in 2015 and was instrumental in establishing operations across Australia and New Zealand. Mez brings with him over 20 years of expertise in medical devices, pharmaceuticals and biotechnology. Prior to FBD, Mez held pivotal positions at Stryker, Merck, Abbott and LEO Pharma. He is passionate about making quality pharmaceuticals/medical technologies accessible to all patients to improve health outcomes. Mez received his Bachelor of Nursing from the University of Sydney and has worked in leading hospital ICU’s across Sydney and London.
Hélène Raineri
Country Manager France
Hélène Raineri has always been attracted by sciences and the medical field and decided to build her career in this industry. With an original academic qualification in Marketing, Hélène is graduated from Skema Business School in 2001. After more than 10 years in the medical aesthetic industry, she joined the company in 2017, seduced by “The Science behind the treatment” and the innovative FLE technology, with the challenge of launching on the French market FB Dermatology therapeutic alternatives.
